Table 3 GO terms and KEGG pathways where the candidate genes significantly (p < 0.05) enriched
Traitsa | Termb | Count | Genes | P-Value |
|---|---|---|---|---|
lnNcells | GO:0045639~positive regulation of myeloid cell differentiation | 2 | CSF3 | 0.017295 |
GO:0043401~steroid hormone mediated signaling pathway | 2 | THRA, NR1D1 | 0.045478 | |
GO:0005130~granulocyte colony-stimulating factor receptor binding | 2 | CSF3 | 0.006326 | |
GO:0030234~enzyme regulator activity | 2 | PSMD3, MTMR9 | 0.034316 | |
ssc04919:Thyroid hormone signaling pathway | 3 | THRA, GATA4, MED24 | 0.040606 | |
MOT | GO:0006874~cellular calcium ion homeostasis | 3 | SLC24A4, ATP2C1, SLC30A1 | 0.010583 |
GO:0006468~protein phosphorylation | 3 | ST3GAL1, NEK2, PIK3R4 | 0.027143 | |
GO:0004672~protein kinase activity | 3 | NEK2, MAP3K14, PIK3R4 | 0.041698 | |
PMOT | GO:0006163~purine nucleotide metabolic process | 3 | NME2, NME1, ADSL | 0.000208 |
GO:0006220~pyrimidine nucleotide metabolic process | 2 | NME2, NME1 | 0.026186 | |
GO:0006241~CTP biosynthetic process | 2 | NME2, NME1 | 0.029872 | |
GO:0009142~nucleoside triphosphate biosynthetic process | 2 | NME2, NME1 | 0.029872 | |
GO:0006228~UTP biosynthetic process | 2 | NME2, NME1 | 0.029872 | |
GO:0006183~GTP biosynthetic process | 2 | NME2, NME1 | 0.037203 | |
GO:0044822~poly(A) RNA binding | 7 | TUFM, ATXN2L, UTP18, NME1, NIP7, SNTB2, DNM1 | 0.04506 | |
ssc01100:Metabolic pathways | 10 | ST6GALNAC6, NME2, PIP5KL1, PTGES2, ST6GALNAC4, GMDS, NME1, ADSL, DPM2, FDFT1 | 0.039824 | |
ssc01130:Biosynthesis of antibiotics | 4 | NME2, NME1, ADSL, FDFT1 | 0.043421 | |
ABN | GO:0014886~transition between slow and fast fiber | 2 | GTF2I, GTF2IRD1 | 0.004569 |
GO:0007605~sensory perception of sound | 3 | USH1G, RPL38, SLC9A3R1 | 0.008744 | |
GO:0001958~endochondral ossification | 2 | IMPAD1, PEX7 | 0.035996 |